| Previous Close | 49.27 |
| Open | 49.18 |
| Bid | 49.31 x 400 |
| Ask | 49.32 x 2200 |
| Day's Range | 48.99 - 49.36 |
| 52 Week Range | 36.76 - 49.59 |
| Volume | 2,623,030 |
| Avg. Volume | 6,685,928 |
| Market Cap | 85.51B |
| Beta | 1.54 |
| PE Ratio (TTM) | 51.28 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.06 (2.15%) |
| Ex-Dividend Date | 2017-04-11 |
| 1y Target Est | N/A |
Capital Cube•4 days agoAbbott Laboratories :ABT-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017
Categories: Yahoo FinanceGet free summary analysis Abbott Laboratories reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Abbott Laboratories – Pfizer Inc., Johnson & Johnson, Hologic, Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, Mylan N.V., Medtronic plc, Thermo Fisher Scientific Inc. and Boston Scientific Corporation (PFE-US, JNJ-US, ... Read more (Read more...)